Arterial Blood Gas Kits Market Analysis and Size by 2031
The arterial blood gas kits market size is projected to reach US$ 1,298.03 million by 2031 from US$ 712.46 million in 2023. The market is expected to register a CAGR of 7.8% during 2023–2031. The development of safe and automated kits, and the integration of electronic medical records is likely to remain a key trend in the market.
Arterial Blood Gas Kits Market Analysis
The increasing prevalence of kidney diseases and metabolic diseases, technological advancements in arterial blood gas kits, and growing emphasis on personalized medicines in developed countries are the factors favoring the arterial blood gas kits market progress. The surging adoption of point-of-care diagnostics in emerging countries is also expected to benefit the market in the coming years.
Arterial Blood Gas Kits Market Overview
India is expected to register the highest CAGR in the global arterial blood gas kits market during 2023–2031. In India, respiratory diseases are responsible for the poor quality of life among the people. A surge in the awareness of respiratory diseases such as asthma, COPD, and respiratory syndrome would offer lucrative growth opportunities to the market in the country. Respiratory distress syndrome (RDS) is a common breathing disorder observed in premature babies in India, causing 150,000 deaths annually. According to a report by the Global Burden of Disease (GBD), chronic obstructive pulmonary disease (COPD) is the second leading cause of death and disability-adjusted life years (DALYs) in India. As per the Lancet Global Health data released in April 2020, asthma was a cause of illness in ~300 million people in the world, and 37.9 million of these people were Indians. Statistics by the Government of India indicate that India, the world's second-most populated country, has seen a tremendous demographic shift in the last 50 years, with nearly a tripling of the elderly population over the age of 60. According to a BQ Prime article, ~138 million people in India aged 60 years and above in 2021, and the number is expected to reach 194 million by the end of 2031. The elderly population in India is estimated to surpass the population of children under 14 years by 2050. Aging is an independent predictor of acute respiratory disease, particularly in critically ill older individuals. For instance, Dr. M.G.R. Educational and Research Institute University is conducting a study named the "Analysis of Arterial Blood Gas (ABG) Profile in Patients with Acute Heart Failure in Tertiary Care Centre at ACS Medical College," in which they studied the pattern of arterial blood gas results in heart failure patients that are admitted to tertiary care center. Thus, the arterial blood gas kits market in India is likely to flourish in the coming years due to the growing geriatric population and ongoing research activities in respiratory care.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Arterial Blood Gas Kits Market: Strategic Insights
Arterial Blood Gas Kits Market
-
CAGR (2023 - 2031)
7.8%
-
Market Size 2023
US$ 712.46 Million
-
Market Size 2031
US$ 1,298.03 Million
Market Dynamics
GROWTH DRIVERS
- Increasing incidence of respiratory diseases requiring measurement of blood gas levels
FUTURE TRENDS
- Rising number of admissions to emergency units in hospitals which reuire contnuous monitoring of blood statistics
OPPORTUNITIES
- Surging Adoption of Point-of-Care Diagnostics in Emerging Countries
Key Players
- BD
- Radiometer Medical ApS
- Vyaire Medical Inc
- Opti Medical Systems
- Siemens Healthineers AG
- AdvaCare Pharma USA LLC
- Becton Dickinson and Co
- ICU Medical Inc
- SunMed Group Holdings LLC AirLife
- Trudell Healthcare Solutions Inc
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
Syringe Type
- Luer Slip Syringe
- Luer Lock Syringe
Type
- Vented
- Non-Vented
Usage
- Pre-Set Plunger Mode
- Manual Aspiration
Application
- In Vitro Diagnostics
- Electrolyte Analysis
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Arterial Blood Gas Kits Market: Strategic Insights
-
CAGR (2023 - 2031)7.8% -
Market Size 2023
US$ 712.46 Million -
Market Size 2031
US$ 1,298.03 Million
Market Dynamics
- Increasing incidence of respiratory diseases requiring measurement of blood gas levels
- Rising number of admissions to emergency units in hospitals which reuire contnuous monitoring of blood statistics
- Surging Adoption of Point-of-Care Diagnostics in Emerging Countries
Key Players
- BD
- Radiometer Medical ApS
- Vyaire Medical Inc
- Opti Medical Systems
- Siemens Healthineers AG
- AdvaCare Pharma USA LLC
- Becton Dickinson and Co
- ICU Medical Inc
- SunMed Group Holdings LLC AirLife
- Trudell Healthcare Solutions Inc
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
- Luer Slip Syringe
- Luer Lock Syringe
- Vented
- Non-Vented
- Pre-Set Plunger Mode
- Manual Aspiration
- In Vitro Diagnostics
- Electrolyte Analysis
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Arterial Blood Gas Kits Market Drivers and Opportunities
Increasing Incidence of Respiratory Diseases Favors Market
Respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), and pneumonia lead to a huge burden on public healthcare systems in various countries across the world. Infections, smoking, and genetic factors can cause serious respiratory complications. In 2021, the American Lung Association ranked COPD third among the leading causes of death in the US, and over 16.4 million people are diagnosed with the condition that year. The article "Effectiveness of a Home Telemonitoring Program for Patients with Chronic Obstructive Pulmonary Disease in Germany," published by the National Library of Medicine in 2022, estimates that Germany reported ∼6 million COPD cases. The article titled "What Knows a Frail Swiss Population About Chronic Obstructive Pulmonary Disease?", published in 2021, estimated that ~400,000 people were affected by COPD in Switzerland. As per the Asthma and Allergy Foundation of America, ∼26 million people in the US suffered from asthma in 2022. The United Nations International Children's Emergency Fund (UNICEF) stated that nearly 1,400 per 100,000 children, i.e., 1 case per 71 children, are diagnosed with pneumonia every year. Breathing issues and oxygen shortages are common in patients suffering from respiratory disorders. Arterial blood gas (ABG) tests are performed to measure oxygen and carbon dioxide gases dissolved in blood. The test serves as a basis of care delivered to patients suffering from acute and chronic respiratory disease. Thus, the surging incidences of acute and chronic respiratory diseases propel the demand for arterial blood gas test kits.
Surging Adoption of Point-of-Care Diagnostics in Emerging Countries to Create Market Opportunities
The inability to run rapid diagnoses is a significant cause of deaths resulting from various diseases in emerging countries. An effective diagnostic infrastructure requires stable electrical power, sophisticated instruments, expensive reagents, and highly trained professionals; thus, diagnoses in developing countries are often limited by the unavailability of these resources. Moreover, the existing diagnostic capabilities result in long assay times, rendering them unsuitable for settings with limited resource availability. Point-of-care testing offers immediate diagnostic results at or near the patient's location, enabling rapid clinical decision-making, streamlined workflows, and enhanced patient outcomes. The need for timely interventions, efficient diagnostic processes, and personalized healthcare delivery fuels the demand for decentralized testing solutions. Point-of-care arterial blood gas kits allow healthcare providers to perform critical diagnostic tests at the patient's bedside, in emergency departments, or in remote settings, facilitating on-the-spot assessment of blood gas parameters, electrolyte levels, and acid-base status. The accessibility and immediacy of point-of-care analyzers empower clinicians to promptly initiate appropriate treatments, monitor patient responses in real-time, and optimize clinical decision-making in acute care scenarios. The shift toward point-of-care diagnostics also drives technological advancements in arterial blood gas kits as manufacturers focus on developing compact, automated, and easy-to-use devices that deliver accurate and fast results. The seamless integration of point-of-care analyzers into healthcare workflows enhances operational efficiency, reduces turnaround times, and improves overall patient care quality. Thus, as healthcare settings embrace the advantages of point-of-care testing, the demand for portable and user-friendly arterial blood gas kits is rising in developing countries, which is likely to create growth opportunities for the market in the coming years.
Arterial Blood Gas Kits Market Report Segmentation Analysis
Key segments that contributed to the derivation of the arterial blood gas kits market analysis are syringe type, usage, type, needle gauge, syringe volume , application, and end user.
- Based on syringe type, the arterial blood gas kits market is segmented into adult Luer slip syringe and Luer lock syringe. The Luer lock syringe segment held a larger market share in 2023.
- By type, the market is segmented into vented and non-vented. The vented segment held a larger share of the market in 2023.
- Based on usage, the market is segmented into pre-set plunger mode and manual aspiration. The pre-set plunger mode segment held a larger share of the market in 2023.
- By application, the market is segmented into in vitro diagnostics and electrolyte analysis. The vitro diagnostics segment is further segmented into pH blood gas, oxygen content, and others. The in vitro diagnostics segment held a larger share of the market in 2023.
- Based on needle gauge, the arterial blood gas kits market is segmented into 23G, 23G to 25G, and greater than 25G. The 23G to 25G segment held the largest market share in 2023.
- Based on syringe volume, the arterial blood gas kits market is segmented into 1 ml, 3 ml, and others. The 3 ml segment held the largest market share in 2023.
- Based on end user, the market is segmented into hospitals and clinics, diagnostic laboratories, and others. The hospitals and clinics segment dominated the market in 2023.
Arterial Blood Gas Kits Market Share Analysis by Geography
The geographic scope of the arterial blood gas kits market report is mainly divided into five regions: North America, Asia Pacific, Europe, the Middle East & Africa, and South & Central America. North America dominated the market in 2023. The North America arterial blood gas kits market has been analyzed on the basis of the US, Canada, and Mexico. Increasing prevalence and incidence of chronic heart and respiratory diseases result in the increased use of arterial blood gas test kits in North American countries. The US held the largest share of the arterial blood gas kits market in North America in 2023. The growing prevalence of chronic diseases necessitating arterial blood gas analysis, including respiratory failure, acute respiratory distress syndrome (ARDS), asthma, diabetic ketoacidosis, renal tubular acidosis, heart failure (HF), and congenital metabolic diseases, is the major factor contributing to the largest share of the US in the arterial blood gas kits market. Additionally, the rising number of collaboration initiatives by research organizations to explore innovative therapeutic applications are projected to accelerate the demand for arterial blood gas kits. Radiometer, BD, and Siemens Healthineers AG are among the major arterial blood gas kit manufacturers operating across North America.
Arterial Blood Gas Kits Market Report Scope
Report Attribute | Details |
---|---|
Market size in 2023 | US$ 712.46 Million |
Market Size by 2031 | US$ 1,298.03 Million |
Global CAGR (2023 - 2031) | 7.8% |
Historical Data | 2021-2022 |
Forecast period | 2024-2031 |
Segments Covered |
By Syringe Type
|
Regions and Countries Covered | North America
|
Market leaders and key company profiles |
|
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Arterial Blood Gas Kits Market News and Recent Developments
The arterial blood gas kits market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the arterial blood gas kits market are listed below:
- AirLife (formerly SunMed) announced the opening of its newest distribution center in Glendale, Arizona. This milestone signifies AirLife's dedication to providing exceptional customer service through improved shipping efficiency and order fulfillment. The new distribution center, spanning an area of 326,018 square feet, comprises 2,520 square feet of front office space, 323,498 square feet of air-conditioned operational space, 59 shipping/receiving docks, and 1,065 square feet of cold room storage. The facility's material handling equipment operates using advanced lithium-ion batteries for energy efficiency. [Source: AirLife (SunMed Medical), Company Website, February 2024]
Arterial Blood Gas Kits Market Report Coverage and Deliverables
The "Arterial Blood Gas Kits Market Size and Forecast (2021–2031)" report provides a detailed analysis of the market covering below areas:
- Arterial blood gas kits market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Arterial blood gas kits market trends as well as market dynamics such as drivers, restraints, and key opportunities
- Detailed PEST/Porter's Five Forces and SWOT analysis
- Arterial blood gas kits market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
- Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the arterial blood gas kits market
- Detailed company profiles
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Product, Type, Usage, Application, Needle Gauge, Syringe Volume, and End User
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
The arterial blood gas kits market is anticipated to record a CAGR of 7.8% during 2023–2031.
BD, Radiometer Medical ApS, Vyaire Medical Inc, Opti Medical Systems, Siemens Healthineers AG, AdvaCare Pharma USA LLC, Becton Dickinson and Co, ICU Medical Inc, SunMed Group Holdings LLC ( AirLife), Trudell Healthcare Solutions Inc, Siemens Healthineers, SARSTEDT AG & Co KG, Lepu Medical Technology Beijing Co Ltd, and Levram Lifesciences Pvt. Ltd. are among the key players operating in the market.
North America dominated the market in 2023.
The increasing incidence of respiratory diseases and rising number of admissions to emergency units in hospitals are among the most influential factors bolstering the market growth.
The development of safe & automated kits and integration of electronic medical records are likely to remain key trends in the arterial blood gas kits market.
The arterial blood gas kits market value is estimated to reach US$ 1,298.03 million in 2031.
The development of safe & automated kits and integration of electronic medical records are likely to remain key trends in the arterial blood gas kits market.
- Radiometer Medical ApS
- Vyaire Medical Inc
- Opti Medical Systems
- Siemens Healthineers AG
- AdvaCare Pharma USA LLC
- Becton Dickinson and Co
- ICU Medical Inc
- SunMed Group Holdings LLC (AirLife)
- Trudell Healthcare Solutions Inc
- SARSTEDT AG & Co KG
- Lepu Medical Technology Beijing Co Ltd
- Levram Lifesciences Pvt. Ltd.